These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6840814)

  • 1. Increased humoral and cellular immunity in mice inoculated with allogeneic tumor cells attached to microcarrier beads.
    Yefenof E; Schwartz S; Katz-Gross A
    Immunol Lett; 1983 Jan; 6(1):39-43. PubMed ID: 6840814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bacille Calmette-Guérin on the immune response of BALB/c mice to a tumor allograft.
    Treagan L; Chen TH; Rambo O; Elberg SS
    J Infect Dis; 1979 Oct; 140(4):541-5. PubMed ID: 117062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of antibodies to allogeneic tumor cells by mouse spleen in vitro.
    Jolley GM
    Cell Immunol; 1976 Jul; 25(1):52-9. PubMed ID: 963748
    [No Abstract]   [Full Text] [Related]  

  • 5. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays.
    Dorfman NA; Civin CI; Wunderlich JR
    J Immunol Methods; 1980; 32(2):127-39. PubMed ID: 7358991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The destruction of allogeneic tumour cells by antibody and adherent cells from peritoneal cavities of mice.
    Jolley GM; Boyle MD; Ormerod MG
    Cell Immunol; 1976 Mar; 22(2):262-70. PubMed ID: 1277297
    [No Abstract]   [Full Text] [Related]  

  • 8. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
    Gillette RW; Berringer DC; Wunderlich DA
    J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antigen elimination by cytotoxic T cells results in diminished cellular immune responses to allogeneic tumor.
    Sugarbaker PH; Matthews W
    Cell Immunol; 1981 Jan; 57(1):114-23. PubMed ID: 6971155
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumours can act as adjuvants for humoral immunity.
    Brown DM; Fisher TL; Wei C; Frelinger JG; Lord EM
    Immunology; 2001 Apr; 102(4):486-97. PubMed ID: 11328383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.
    Gorelik E; Wiltrout RH; Okumura K; Habu S; Herberman RB
    Int J Cancer; 1982 Jul; 30(1):107-12. PubMed ID: 7118294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.